Atrás
Rango del Día
$98.15
$102.06
Rango de 52 Semanas
$39.60
$105.69
Volumen
905,200
Promedio 50D / 200D
$87.11
/
$72.76
Cierre Anterior
$98.87
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (626 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -48.3 | 0.4 |
| P/B | 10.2 | 2.9 |
| ROE % | -20.2 | 3.8 |
| Net Margin % | -282.8 | 3.9 |
| Rev Growth 5Y % | 13.9 | 10.0 |
| D/E | 0.0 | 0.2 |
Precio Objetivo de Analistas
Hold
$113.60
+15.3%
Low: $108.00
High: $121.00
P/E Futuro
30.5
EPS Futuro
$3.23
Crecimiento EPS (est.)
+0.0%
Ingresos Est.
440 M
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
$4.65
-$0.61 – $9.06
|
600 M | 2 |
| FY2029 |
$2.57
-$0.34 – $5.01
|
420 M | 4 |
| FY2028 |
$1.56
-$7.56 – $10.54
|
300 M | 6 |
Puntos Clave
Revenue grew 13.88% annually over 5 years — strong growth
Earnings declined -147.29% over the past year
Debt/Equity of 0.02 — conservative balance sheet
Generating 56.08M in free cash flow
PEG of 0.29 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 103.29%
Crecimiento
Revenue Growth (5Y)
13.88%
Revenue (1Y)-89.41%
Earnings (1Y)-147.29%
FCF Growth (3Y)N/A
Calidad
Return on Equity
-20.18%
ROIC-18.97%
Net Margin-282.83%
Op. Margin-343.63%
Seguridad
Debt / Equity
0.02
Current Ratio12.71
Interest Coverage0.00
Valoración
P/E Ratio
-48.31
P/B Ratio10.23
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -89.41% | Revenue Growth (3Y) | -12.43% |
| Earnings Growth (1Y) | -147.29% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 13.88% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 46.02M | Net Income (TTM) | -130.15M |
| ROE | -20.18% | ROA | -19.43% |
| Gross Margin | 97.34% | Operating Margin | -343.63% |
| Net Margin | -282.83% | Free Cash Flow (TTM) | 56.08M |
| ROIC | -18.97% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.02 | Current Ratio | 12.71 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -48.31 | P/B Ratio | 10.23 |
| P/S Ratio | 136.64 | PEG Ratio | 0.29 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 6.29B | Enterprise Value | 6.17B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 46.02M | 434.43M | 60.00M | 26.58M | 27.36M |
| Net Income | -130.15M | 275.19M | -78.96M | -127.39M | -125.55M |
| EPS (Diluted) | -2.05 | 4.23 | -1.39 | -2.52 | -2.65 |
| Gross Profit | 44.79M | 434.43M | 60.00M | 26.58M | 27.36M |
| Operating Income | -158.13M | 252.84M | -93.65M | -131.37M | -125.85M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 669.89M | 744.73M | 357.95M | 247.93M | 347.70M |
| Total Liabilities | 55.19M | 69.43M | 21.27M | 32.32M | 47.67M |
| Shareholders' Equity | 614.71M | 675.30M | 336.68M | 215.61M | 300.02M |
| Total Debt | 10.32M | 10.87M | 1.14M | 3.66M | 5.86M |
| Cash & Equivalents | 128.39M | 97.25M | 186.73M | 125.74M | 123.67M |
| Current Assets | 577.57M | 591.64M | 355.58M | 243.08M | 340.74M |
| Current Liabilities | 45.44M | 47.40M | 21.27M | 31.18M | 44.02M |